Free Trial
NASDAQ:HSIC

Henry Schein Q2 2025 Earnings Report

Henry Schein logo
$73.95 +0.50 (+0.68%)
Closing price 04:00 PM Eastern
Extended Trading
$73.38 -0.58 (-0.78%)
As of 07:22 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Henry Schein EPS Results

Actual EPS
N/A
Consensus EPS
$1.19
Beat/Miss
N/A
One Year Ago EPS
N/A

Henry Schein Revenue Results

Actual Revenue
N/A
Expected Revenue
$3.22 billion
Beat/Miss
N/A
YoY Revenue Growth
N/A

Henry Schein Announcement Details

Quarter
Q2 2025
Time
Before Market Opens
Conference Call Date
Tuesday, August 5, 2025
Conference Call Time
10:00AM ET

Conference Call Resources

Henry Schein Earnings Headlines

Forget Nvidia, This “Ghost Town” Company Holds the Key to the AI Boom
Cold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to investigate this crazy Cold War story… Because it could hold the key to the entire $100 trillion AI boom. It involves an American ghost town with just 30 people… And a new twist to the AI boom that could make a lot of people rich.
Head-To-Head Contrast: Henry Schein (HSIC) versus Its Rivals
Head-To-Head Comparison: Henry Schein (HSIC) & Its Rivals
Henry Schein, Inc. (HSIC) - Yahoo Finance
See More Henry Schein Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Henry Schein? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Henry Schein and other key companies, straight to your email.

About Henry Schein

Henry Schein (NASDAQ:HSIC) (NASDAQ:HSIC) is a leading global distributor of healthcare products and services, serving practitioners in the dental, medical and animal health markets. The company’s comprehensive portfolio spans consumable products, equipment, technology solutions and value-added services designed to help healthcare professionals improve operational efficiency and patient outcomes. Henry Schein’s distribution network leverages advanced logistics capabilities and a proprietary digital platform to support timely delivery and responsive customer service.

The company offers an extensive range of dental supplies, including restorative materials, imaging systems and dental laboratory products, alongside medical supplies such as exam gloves, surgical instruments and diagnostic test kits. In the animal health segment, Henry Schein provides vaccines, pharmaceuticals, imaging equipment and nutritional products tailored to veterinarians and their patients. Complementing its product offerings, the company delivers practice management software, clinical education and consulting services that enable practitioners to streamline workflows, optimize inventory and enhance clinical decision-making.

Founded in 1932 by Henry Schein, the firm has grown through strategic acquisitions and continuous innovation to maintain a broad and diverse catalog of healthcare solutions. Over the decades, the company has expanded its footprint beyond the United States to establish a presence in more than 30 countries, supported by regional warehouses and a dedicated sales force. This global reach allows Henry Schein to address the unique needs of practitioners in both mature and emerging markets while benefiting from economies of scale in procurement and distribution.

Under the leadership of Stanley M. Bergman, who serves as Chairman and Chief Executive Officer, Henry Schein has reinforced its commitment to ethical business practices and community engagement. The company’s executive team includes seasoned professionals with deep expertise in healthcare, technology and supply chain management, positioning Henry Schein to adapt to evolving industry trends and regulatory environments. Through ongoing investments in digital transformation and service innovation, Henry Schein aims to deliver long-term value to customers, partners and stakeholders worldwide.

View Henry Schein Profile

More Earnings Resources from MarketBeat